Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR )

6.340 +0.340 (+5.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 199,023
Open 6.100
Bid (Size) 5.170 (1)
Ask (Size) 6.010 (4)
Prev. Close 6.000
Today's Range 5.930 - 6.380
52wk Range 4.470 - 9.085
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire

Performance

YTD
-0.63%
-0.63%
1 Month
-0.63%
-0.63%
3 Month
+13.62%
+13.62%
6 Month
-23.80%
-23.80%
1 Year
-24.34%
-24.34%

More News

Read More
Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via Business Wire
Pending Lead Plaintiff Deadline in the LFCR Class Action: Robbins LLP Reminds Stockholders With Large Losses of Lifecore Biomedical, Inc. to Seek Counsel
From Robbins LLP
Via GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
From Faruqi & Faruqi LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Shareholder Rights Law Firm Robbins LLP Urges LFCR Stockholders to Contact the Firm for Information About the Lifecore Biomedical, Inc. Class Action
From Robbins LLP
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
From Faruqi & Faruqi LLP
Via GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
LFCR CLASS ACTION ALERT: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Lifecore Biomedical, Inc. Class Action
From Robbins LLP
Via GlobeNewswire
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR
From The Rosen Law Firm PA
Via GlobeNewswire
Poulin I Willey I Anastopoulo Announces A Class Action Lawsuit Has Been Filed Against Lifecore Biomedical, Inc. (LFCR)
From Poulin | Willey | Anastopoulo, LLC
Via GlobeNewswire
Lifecore Biomedical, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the LFCR Class Action Lawsuit
From Robbins LLP
Via Business Wire
LFCR CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Lifecore Biomedical Inc. (LFCR) and Lead Plaintiff Deadline on September 27, 2024
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
LFCR CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Lifecore Biomedical Inc. (LFCR) and Lead Plaintiff Deadline on September 27, 2024
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via GlobeNewswire
LFCR SHAREHOLDER ACTION ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Lifecore Biomedical Inc. (LFCR) and Lead Plaintiff Deadline on September 27, 2024
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.